D449 Psychology and Mental Health - Set 2 - Part 2

Correct Answer: Benztropine for EPS symptom treatment

Option d is correct because benztropine is an anticholinergic medication used to treat extrapyramidal symptoms like acute dystonia, which presents with sudden neck spasms, involuntary eye movements, and swallowing difficulties from antipsychotic use. Option a is incorrect because dantrolene is specifically used to treat neuroleptic malignant syndrome with its characteristic high fever and severe muscle rigidity, not the acute dystonic reactions presenting with neck spasms and eye rolling seen here. Option b is incorrect because flumazenil is the antidote for benzodiazepine overdose that works by displacing benzodiazepines from their receptors, and it has no role in treating extrapyramidal symptoms caused by antipsychotic medications at all. Option c is incorrect because naloxone is an opioid antagonist used to reverse opioid overdose and respiratory depression, and it does not address the dopamine-acetylcholine imbalance causing extrapyramidal symptoms from antipsychotic medications.

Correct Answer: Restores dopamine-acetylcholine balance

Option a is correct because benztropine is an anticholinergic drug that restores the balance between dopamine and acetylcholine in brain regions controlling muscle movement, thereby improving the movement side effects from antipsychotic medications. Option b is incorrect because benztropine does not affect serotonin receptor sensitivity, as its mechanism specifically targets the cholinergic system to counteract the dopamine-acetylcholine imbalance created by dopamine-blocking antipsychotic medications. Option c is incorrect because blocking GABA inhibitory pathways is not benztropine's mechanism; GABA enhancement is the mechanism of benzodiazepines, while benztropine specifically works by reducing acetylcholine activity to restore neurochemical balance. Option d is incorrect because enhancing norepinephrine reuptake describes a mechanism unrelated to benztropine's action, which focuses on anticholinergic activity in the basal ganglia to correct movement dysfunction caused by

Correct Answer: Anticholinergic effect presentation

Option c is correct because dry mouth, constipation, blurred vision, and urinary retention are classic anticholinergic effects commonly associated with first-generation antipsychotics like thioridazine, resulting from acetylcholine receptor blockade throughout the body. Option a is incorrect because extrapyramidal symptoms involve movement abnormalities such as dystonia, akathisia, tremors, and tardive dyskinesia rather than the autonomic symptoms of dry mouth, constipation, and urinary retention described in this scenario. Option b is incorrect because metabolic syndrome involves weight gain, hyperglycemia, and cholesterol elevation primarily associated with second-generation antipsychotics, which differs from the autonomic nervous system effects this patient is currently experiencing. Option d is incorrect because serotonin syndrome presents with agitation, fever, diaphoresis, and muscle tremors from excess serotonergic activity, which is distinct from the anticholinergic symptoms of

Correct Answer: Haloperidol causes imbalance benztropine corrects

Option b is correct because haloperidol blocks dopamine receptors, creating an imbalance between dopamine and acetylcholine that causes extrapyramidal symptoms, and benztropine corrects this by reducing acetylcholine activity in affected brain areas. Option a is incorrect because benztropine does not enhance haloperidol's antipsychotic therapeutic effects; it manages the unwanted movement side effects by addressing the neurochemical imbalance that haloperidol's dopamine blockade creates in motor pathways. Option c is incorrect because haloperidol and benztropine target different neurotransmitter systems; haloperidol blocks dopamine receptors to reduce psychotic symptoms while benztropine blocks acetylcholine receptors to restore balance and reduce movement disorders. Option d is incorrect because benztropine does not prevent haloperidol from working; it specifically targets the cholinergic system to manage side effects while allowing haloperidol to continue its therapeutic do

Correct Answer: Patients with antipsychotic movement reactions

Option d is correct because benztropine is an anticholinergic medication primarily used to treat extrapyramidal symptoms that develop as movement-related side effects in patients taking antipsychotic medications, particularly first-generation typical antipsychotics. Option a is incorrect because acute anxiety episodes are typically treated with benzodiazepines such as lorazepam or diazepam that enhance GABA activity, not with anticholinergic medications like benztropine which specifically target movement disorders. Option b is incorrect because alcohol withdrawal is managed with benzodiazepines, thiamine supplementation, and fluid replacement rather than benztropine, which specifically addresses the extrapyramidal symptoms caused by antipsychotic medication therapy only. Option c is incorrect because bipolar depressive episodes are primarily treated with mood stabilizers like lithium and certain atypical antipsychotics rather than benztropine, which has no mood-stabilizing properties a

Correct Answer: They block serotonin from being reabsorbed

Option a is correct because SSRIs work by inhibiting the reuptake of serotonin at the synaptic cleft, allowing more serotonin to remain available in the brain and gradually improving mood and emotional regulation over time. Option b is incorrect because SSRIs do not affect dopamine receptor sensitivity as their primary mechanism; dopamine modulation is more associated with antipsychotic medications, while SSRIs specifically target the serotonin reuptake transporter to increase serotonin availability. Option c is incorrect because SSRIs do not enhance norepinephrine breakdown; medications that affect norepinephrine include SNRIs which inhibit both serotonin and norepinephrine reuptake, a fundamentally different mechanism from selective serotonin reuptake inhibition. Option d is incorrect because SSRIs have no direct effect on acetylcholine production rates, as their mechanism is highly selective for serotonin reuptake inhibition, and acetylcholine modulation is associated with anticholi

Correct Answer: Discontinue serotonergic agents and notify provider

Option c is correct because serotonin syndrome is a potentially life-threatening condition requiring immediate discontinuation of all serotonin-enhancing medications and prompt provider notification to prevent rapid clinical deterioration and potential organ damage. Option a is incorrect because administering oral fluids is a supportive measure that does not address the underlying cause of serotonin syndrome, and the priority action must focus on stopping the offending serotonergic agents causing the dangerous reaction. Option b is incorrect because while cooling measures may be part of supportive care for hyperthermia, they do not address the root cause and the nurse must first discontinue the serotonergic medications driving the syndrome before implementing comfort measures. Option d is incorrect because simply increasing monitoring frequency without discontinuing the causative medications allows the serotonin syndrome to continue progressing, potentially leading to seizures, rhabdom

Correct Answer: Selective serotonin reuptake inhibitors

Option b is correct because sertraline, fluoxetine, paroxetine, citalopram, and escitalopram are all classified as selective serotonin reuptake inhibitors used to treat depression, anxiety, obsessive-compulsive disorder, and post-traumatic stress disorder. Option a is incorrect because tricyclic antidepressants include medications such as amitriptyline and imipramine, which have a different mechanism involving both serotonin and norepinephrine reuptake inhibition along with significant anticholinergic side effects. Option c is incorrect because monoamine oxidase inhibitors include medications like selegiline, phenelzine, and isocarboxazid, which work by inhibiting the monoamine oxidase enzyme rather than selectively blocking serotonin reuptake at the synapse. Option d is incorrect because serotonin-norepinephrine reuptake inhibitors include medications such as duloxetine, which inhibit the reuptake of both serotonin and norepinephrine, unlike the selective serotonin-only mechanism of t

Correct Answer: Expected SSRI side effect profile

Option d is correct because weight gain, sexual dysfunction, and insomnia are well-documented side effects of SSRI medications like fluoxetine, representing expected pharmacological responses rather than dangerous reactions or treatment failure. Option a is incorrect because the presence of side effects does not indicate therapeutic failure; side effects and therapeutic effects are separate pharmacological responses, and the medication may still be effectively treating the patient's depression despite these complaints. Option b is incorrect because insomnia, sexual dysfunction, and gradual weight gain are common and manageable SSRI side effects that do not require emergency intervention, unlike serotonin syndrome which presents with acute fever, agitation, and neuromuscular changes. Option c is incorrect because serotonin syndrome presents acutely with agitation, hyperthermia, diaphoresis, and tremors, which is distinctly different from the chronic and gradually developing side ef

Correct Answer: Full therapeutic effects take two-plus weeks

Option a is correct because SSRIs require two or more weeks before patients experience the full antidepressant effects, and educating the patient about this expected timeline is essential for promoting medication adherence and treatment success. Option b is incorrect because recommending St. John's Wort with an SSRI is dangerous and contraindicated, as the combination increases serotonin levels excessively and significantly raises the risk of developing life-threatening serotonin syndrome. Option c is incorrect because immediately switching medication classes after only five days does not allow adequate time for the SSRI to reach therapeutic effectiveness, and frequent medication changes can delay recovery and confuse symptom assessment. Option d is incorrect because while mild situational sadness may resolve independently, clinical depression is a medical condition that typically requires treatment including pharmacotherapy and psychotherapy for adequate symptom management and re

Correct Answer: Patient with depression and specific overdose plan

Option c is correct because having a specific suicide plan is one of the most critical risk factors for completed suicide, and a depressed patient who describes a detailed method of overdose requires the most immediate safety intervention and monitoring. Option a is incorrect because while anxiety and insomnia may contribute to distress, this patient does not present with the combination of depression and a specific plan that markedly increases the immediate risk of a suicide attempt requiring urgent intervention. Option b is incorrect because although depression combined with a recent job loss represents significant risk factors, the absence of a specific suicide plan makes this patient lower priority than someone who has already formulated a detailed method for self-harm. Option d is incorrect because suicide risk assessment uses a hierarchy of risk factors to prioritize care, and a patient with both depression and a formulated plan requires more immediate intervention than patients

Correct Answer: Substance abuse and significant personal loss

Option d is correct because substance abuse combined with significant personal loss represents a high-risk profile for suicidal ideation, as both are well-established independent risk factors that compound danger when occurring together in a patient. Option a is incorrect because mild anxiety and seasonal allergies represent low-acuity health concerns that do not carry the same elevated suicide risk as substance abuse and significant personal loss, which directly correlate with increased suicidal ideation. Option b is incorrect because occasional insomnia and general work stress are common experiences that, while potentially contributing to distress, do not create the same high-risk suicide profile as the combination of substance abuse with significant loss. Option c is incorrect because a recent promotion and new relationship are generally positive life events that would be considered protective factors against suicidal ideation, not risk factors that increase vulnerability to self-ha

Correct Answer: Evaluate for imminent suicide risk immediately

Option a is correct because sudden cheerfulness combined with giving away personal belongings in a previously severely depressed patient starting SSRIs is a critical warning sign that the patient may have resolved to attempt suicide and is preparing. Option b is incorrect because documenting this as treatment success overlooks the dangerous behavioral pattern of giving away possessions, which is a well-recognized warning sign of imminent suicide rather than genuine therapeutic improvement in a depressed patient. Option c is incorrect because attributing this dramatic shift to normal medication adjustment ignores the significant red flag of giving away treasured belongings, which combined with sudden mood elevation in a newly medicated patient signals potential suicide preparation. Option d is incorrect because while manic episodes should be considered with sudden mood elevation, the specific behavior of giving away treasured possessions in a severely depressed young adult on new SSRIs

Correct Answer: Strong social support network present

Option b is correct because strong social connections and support networks serve as protective factors against suicide by providing emotional resources, accountability, and reasons for living that can buffer against suicidal ideation during depressive episodes. Option a is incorrect because a history of previous suicide attempts is one of the strongest risk factors for future suicide attempts, as prior attempts significantly increase the statistical likelihood of subsequent self-harm behaviors rather than protecting against them. Option c is incorrect because current substance use disorder is a well-documented risk factor that increases impulsivity and impairs judgment, thereby elevating rather than reducing the likelihood of suicidal behavior in depressed patients during periods of crisis. Option d is incorrect because access to firearms represents a significant risk factor for completed suicide due to the lethal nature and accessibility of the means, and reducing access to lethal mea

Correct Answer: Increased alcohol use with depression

Option d is correct because increased alcohol use combined with depression creates a compounding risk where substance abuse impairs judgment and increases impulsivity, significantly elevating the likelihood of acting on suicidal thoughts during vulnerable moments. Option a is incorrect because while veteran status is a recognized demographic risk factor for suicide, it represents a static background variable rather than an active and modifiable risk factor like escalating substance abuse combined with current depressive symptoms. Option b is incorrect because although recent divorce is a significant life stressor that contributes to suicide risk, it is a single precipitating event, whereas increasing alcohol use with depression represents an ongoing and escalating pattern that compounds danger continuously. Option c is incorrect because passive thoughts about death without a specific plan represent a lower level of immediate risk compared to the active combination of increasing alcohol

Correct Answer: Electroconvulsive therapy sessions

Option c is correct because electroconvulsive therapy is an established treatment for severe or treatment-resistant depression that uses controlled electrical stimulation to produce therapeutic changes when multiple medication trials have been unsuccessful. Option a is incorrect because vagus nerve stimulation is a different modality that uses a surgically implanted device to deliver electrical impulses to the vagus nerve, typically reserved for chronic treatment-resistant depression rather than as a next-step intervention. Option b is incorrect because transcranial magnetic stimulation uses magnetic fields rather than direct electrical stimulation, and while it treats depression, the scenario specifically describes electrical stimulation consistent with electroconvulsive therapy for treatment-resistant cases. Option d is incorrect because cognitive behavioral therapy is a talk-based psychotherapy approach that helps patients identify and change negative thought patterns, which does no

Correct Answer: Cognitive behavioral therapy techniques

Option a is correct because cognitive behavioral therapy specifically focuses on helping patients identify, challenge, and modify negative thought patterns and maladaptive behaviors that contribute to and maintain depressive symptoms over time. Option b is incorrect because electroconvulsive treatment is a medical procedure using electrical stimulation to treat severe depression, which involves no therapeutic conversation or cognitive restructuring techniques to address harmful thinking patterns directly. Option c is incorrect because pharmacotherapy involves the use of medications to manage depression through chemical neurotransmitter modulation, not the identification and modification of harmful cognitive patterns through therapeutic conversation and homework. Option d is incorrect because milieu therapy creates a structured therapeutic environment that promotes social interaction and community-based healing, rather than specifically targeting individual negative thought patterns thr

Correct Answer: Medications address chemistry while therapy changes thinking

Option b is correct because antidepressant medications work on neurotransmitter imbalances in the brain while psychotherapy like cognitive behavioral therapy helps patients develop healthier thought patterns and coping strategies for lasting improvement. Option a is incorrect because therapy alone can be effective for some patients with depression, particularly those with mild to moderate symptoms, and stating that therapy always fails is inaccurate and may discourage engagement with therapeutic interventions. Option c is incorrect because the rationale for combined treatment is based on clinical evidence showing improved outcomes when medication and therapy work together, not on insurance payment requirements which vary across plans and providers. Option d is incorrect because combined treatment with medication and psychotherapy can benefit patients across the full spectrum of depression severity, not exclusively those with severe presentations, as addressing both biological and psych

Correct Answer: Individual therapy with exercise program

Option d is correct because individual psychotherapy combined with regular exercise provides evidence-based non-pharmacological treatment for adolescent depression that addresses psychological factors through therapy while promoting natural mood improvement through physical activity. Option a is incorrect because physical restraints and seclusion are safety interventions used for immediate danger situations, not therapeutic treatment approaches for depression, and using them as depression treatment would be inappropriate and potentially harmful. Option b is incorrect because electroconvulsive therapy is an invasive procedure reserved for severe treatment-resistant depression and would not be an appropriate first-line non-pharmacological approach, especially when the family seeks to avoid aggressive interventions. Option c is incorrect because vagus nerve stimulation requires surgical device implantation and is reserved for chronic treatment-resistant cases, making it an inappropriately

Correct Answer: Expressing interest in future career goals

Option c is correct because expressing interest in future goals demonstrates improved mood, renewed engagement with life, and forward-looking thinking, all of which indicate effective depression treatment and movement toward recovery in adolescent patients. Option a is incorrect because continued social withdrawal from peers suggests the patient's depression has not improved, as persistent isolation indicates ongoing anhedonia and disengagement that are core symptoms of an unresolved depressive episode. Option b is incorrect because persistent refusal to attend therapy sessions indicates treatment resistance or worsening engagement rather than improvement, suggesting the current approach may need modification to better reach the adolescent patient. Option d is incorrect because increasing angry outbursts in an adolescent may indicate worsening depression rather than improvement, since aggression and irritability are common manifestations of adolescent depression that should decrea